Bath & Body Works price target lowered to $20 from $26 at TD Cowen
TD Cowen analyst Jonna Kim lowered the firm’s price target on Bath & Body Works to $20 from $26 and keeps a Buy rating on the shares. The firm updated…
Fiscal Year: February - January
Bath & Body Works, Inc. (BBWI), listed on the NYSE, has a market capitalization of $3.26B. As of May 19, 2026, the stock is trading at $16.21 per share@else an unavailable price , offering investors a clear view of its current market value. Bath & Body Works, Inc. is a prominent player in the industry sector, attracting both institutional and retail investors due to its performance and potential.
With a P/E ratio of 5.21, investors can assess the stock's valuation in comparison to its earnings. A P/E ratio is a crucial indicator for value investors, showing whether the stock is over or undervalued relative to its current earnings. Bath & Body Works, Inc. also offers a dividend yield of 4.68%, making it an attractive option for income-focused investors who seek regular dividends.
Our Discounted Cash Flow (DCF) analysis reveals that Bath & Body Works, Inc. (BBWI) may be undervalued compared to its intrinsic worth. However, to see the exact DCF fair value, please Login or Upgrade for access.
The proprietary SS Score for Bath & Body Works, Inc. is a unique metric that analyzes the company's financial health and growth potential. The score takes into account critical factors such as revenue growth, net income, free cash flow (FCF) compound annual growth rate (CAGR), the trend of shares outstanding, and the debt-to-FCF ratio. This helps investors to make a more informed decision, as an undervalued stock might still have poor financial fundamentals.
To view the detailed SS Score for Bath & Body Works, Inc., Login or Upgrade for access.
The Price to Free Cash Flow (P/FCF) ratio for Bath & Body Works, Inc. is 3.77, offering insights into how much investors are paying for the company's free cash flow. A lower P/FCF ratio typically suggests that the stock is undervalued, while a higher ratio may indicate overvaluation.
In summary, Bath & Body Works, Inc. (BBWI) has shown consistent financial performance, as illustrated by the financial charts above, which track its revenue growth, net income, free cash flow, and shares outstanding over the past several years. These metrics provide investors with key insights into the company's past and projected future performance. Investors should use the SS Score alongside the DCF Fair Value to make better-informed decisions about whether to buy or hold the stock.
*This analysis is for informational purposes only and does not constitute investment advice. Always read the company's 10-K filings and do your own research before making any investment decisions.
Whether Bath & Body Works, Inc. (BBWI) is a good stock to buy depends on various factors, including its financial health, market conditions, and your investment strategy. Our analysis indicates that the stock may be undervalued compared to its intrinsic value. However, it is important to assess the SS Score and review the company's fundamentals before making any investment decisions.
The fair value of Bath & Body Works, Inc. (BBWI) is determined through our Discounted Cash Flow (DCF) analysis. This value represents the intrinsic worth of the stock based on its expected future cash flows. To view the specific fair value, consider subscribing to our service for complete access.
The SS Score is a proprietary financial quality metric that assesses factors such as revenue growth, net income, free cash flow growth, and debt levels. It helps investors evaluate the overall financial health of Bath & Body Works, Inc.. To access the full SS Score, consider upgrading your subscription.
Bath & Body Works, Inc. is a significant player in the industry sector, with a market capitalization of $3.26B and a competitive P/E ratio of 5.21. Investors should compare these metrics with industry peers to gauge whether Bath & Body Works, Inc. is outperforming or underperforming within its sector.
TD Cowen analyst Jonna Kim lowered the firm’s price target on Bath & Body Works to $20 from $26 and keeps a Buy rating on the shares. The firm updated…
COLUMBUS, Ohio, May 15, 2026 (GLOBE NEWSWIRE) -- Bath & Body Works, Inc. (NYSE: BBWI) announced today the declaration of its regular quarterly dividend of $0.20 per share payable on June 19, 2026, to ...
Piper Sandler assumed coverage of Bath & Body Works with a Neutral rating and $20 price target The firm acknowledges the stock is inexpensive trading at about seven times 2026…
COLUMBUS, Ohio, May 13, 2026 (GLOBE NEWSWIRE) -- Bath & Body Works, Inc. (NYSE: BBWI) announced today that it plans to report its first quarter 2026 financial results before market open on Wednesday, ...
HOUSTON--(BUSINESS WIRE)--LandBridge Company LLC (NYSE: LB; NYSE TX: LB) (the “Company,” or “LandBridge”) today announced its financial and operating results for the first quarter ended March 31, 2026...
Bath & Body Works announced the appointment of Veronique Gabai-Pinsky as its first-ever chief brand& product officer, effectiveMay 18, building on her contributions as a creative product & brand advis...
As chief brand & product officer, Gabai-Pinsky will lead brand, product, creative and design to further accelerate Bath & Body Works' transformation and innovation As chief brand & product officer, Ga...
Bath & Body Works is turning to Amazon as part of its turnaround effort, CEO Daniel Heaf said. The e-commerce giant is helping the mall staple reach new customers.
HOUSTON--(BUSINESS WIRE)--LandBridge Company LLC (NYSE: LB; NYSE TX: LB) ("LandBridge") today announced that it will release its financial results for the first quarter of 2026 after market close on W...
HOUSTON--(BUSINESS WIRE)--LandBridge Company LLC (NYSE: LB) (“LandBridge”) today announced that it has entered into a lease development agreement with PowerBridge LLC (“PowerBridge”) providing the opt...
Bath & Body Works (BBWI) is partnering with Vera Bradley (VRA) on a limited-edition Mother’s Day collaboration that brings together fragrance, design and gifting across body care, home fragrance and…
HOUSTON--(BUSINESS WIRE)--LandBridge Company LLC (NYSE: LB) (the “Company,” or “LandBridge”) will conduct a live video webcast of its Investor Day on March 19, 2026 at 1:00 pm ET. The webcast will be ...
Bath & Body Works stock dipped after analysts weighed in following the company’s latest earnings report.
Telsey Advisory raised the firm’s price target on Bath & Body Works to $25 from $23 and keeps a Market Perform rating on the shares. The firm is encouraged by…
Deutsche Bank raised the firm’s price target on Bath & Body Works to $23 from $22 and keeps a Hold rating on the shares.
Goldman Sachs raised the firm’s price target on Bath & Body Works to $26 from $17 and keeps a Neutral rating on the shares. The company’s new business strategy announced…
JPMorgan lowered the firm’s price target on Bath & Body Works to $22 from $23 and keeps a Neutral rating on the shares. The updated the company’s model post the…
Barclays raised the firm’s price target on Bath & Body Works to $25 from $21 and keeps an Equal Weight rating on the shares. The firm updated the company’s model…
Wells Fargo maintained an Overweight rating and $29 price target on Bath & Body Works following the company’s post-Q4 earnings pullback. The firm added that the turnaround story is “right…
BofA analyst Lorraine Hutchinson raised the firm’s price target on Bath & Body Works to $30 from $26 and keeps a Buy rating on the shares. The firm, which thinks…
Bath & Body Works stock gained on Wednesday after its Q4 results blew past Wall Street’s estimates.
Bath & Body Works reported lower fourth-quarter profit, but said its strategy pivot to refocus on its core products was making progress.
Reports Q4 revenue $2.7B, consensus $2.61B. Daniel Heaf, CEO of Bath & Body Works, commented, “Our fourth quarter results exceeded the guidance we provided. Since launching the Consumer First Formula…
For fiscal 2026, the company is forecasting net sales to decline between 4.5%-2.5% compared to $7.291B in fiscal 2025. FY26 consensus $7.03B
Below estimates were sourced from SimplyWallSt and are intended for educational purposes only as a baseline for the analysis.
| Year | FCF Estimate | % | # Analysts |
|---|---|---|---|
| 2026 | 755.93M | Analyst x3 | |
| 2027 | 581.20M | -23.11% | Analyst x2 |
| 2028 | 709.37M | 22.05% | Analyst x3 |
| 2029 | 1,017.00M | 43.37% | Analyst x1 |
| 2030 | 1,075.00M | 5.70% | Analyst x1 |
| 2031 | 1,112.33M | 3.47% | Est @3.5% |
| 2032 | 1,148.29M | 3.23% | Est @3.2% |
| 2033 | 1,183.42M | 3.06% | Est @3.1% |
| 2034 | 1,215.90M | 2.74% | Est @2.7% |
| 2035 | 1,248.24M | 2.66% | Est @2.7% |
Below are the FCF estimates with the discount factor and the calculated present value with the terminal value that led the results above.
| Year | FCF | Discount Factor | PV of Future FCF |
|---|---|---|---|
| 2024A | -222.00M | 1.00 | -222.00M |
| 2025A | 660.00M | 1.00 | 660.00M |
| 2026E | 755.93M | 1.08 | 699.69M |
| 2027E | 581.20M | 1.17 | 497.93M |
| 2028E | 709.37M | 1.26 | 562.52M |
| 2029E | 1.02B | 1.36 | 746.47M |
| 2030E | 1.08B | 1.47 | 730.34M |
| 2031E | 1.11B | 1.59 | 699.48M |
| 2032E | 1.15B | 1.72 | 668.37M |
| 2033E | 1.18B | 1.86 | 637.57M |
| 2034E | 1.22B | 2.01 | 606.33M |
| 2035E | 1.25B | 2.17 | 576.15M |
| Terminal | 23.10B | 2.17 | 10.66B |
The information given by Studying Stocks and provided in the web and/or mobile applications (Platforms) is only factual information and should not be considered financial advice.
Any information contained in this website has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.
When creating an account, you acknowledge that you are:
We retain the right to cancel your account for any reason, or refuse your account creation request.
The information on our Platforms is not comprehensive and is intended to provide a summary of the subject matter covered. While we use all reasonable attempts to ensure the accuracy and completeness of the data and information on our Platforms, to the extent permitted by law, we make no warranty regarding the information on these Platforms. You should monitor any changes to the information contained on these Platforms.
Furthermore we make no commitments in regards to the minimum amount of uptime that our platforms will maintain, although we will make ever reasonable attempt to ensure that the platforms are operational. Therefore, any reference of "latest", "current" and related words about the financial data presented here may not be up to date with the financial markets or represent reality of the information.
We are not liable to you or anyone else if interference with or damage to your computer systems occurs in connection with the use of these Platforms or a linked website. You must take your own precautions to ensure that whatever you select for your use from our Platforms is free of viruses or anything else (such as worms or Trojan horses) that may interfere with or damage the operations of your computer systems.
We may, from time to time and without notice, change or add to the Platforms (including the Terms) or the information, products or services described in it. However, we do not undertake to keep the Platforms updated. We are not liable to you or anyone else if errors occur in the information or the Platforms is not up-to-date.
Our Platforms may contain links to websites operated by third parties. Those links are provided for convenience and may not remain current or be maintained. Unless expressly stated otherwise, we do not endorse and are not responsible for the content on those linked websites and have no control over or rights in those linked websites.
These Platforms are for your personal, non-commercial use only. You may not modify, copy, distribute, transmit, display, perform, reproduce, publish, license, commercially exploit, create derivative works from, transfer, or sell any Content, software, products or services contained within these Platforms. You may not use these Platforms, or any of its Content, to further any commercial purpose, including any advertising or advertising revenue generation activity on your own website.
You must not do any act that we would deem to be inappropriate, is unlawful or is prohibited by any laws applicable to these Platforms, including but not limited to:
If we allow you to post any information to our Platforms, we have the right to take down this information at our sole discretion and without notice.
To the maximum extent permitted by law, we make no warranties or representations about these Platforms or the Content, including but not limited to warranties or representations that they will be complete, accurate or up-to-date, that access will be uninterrupted or error-free or free from viruses, or that these Platforms will be secure.
We reserve the right to restrict, suspend or terminate without notice your access to these Platforms, any Content, or any feature of these Platforms at any time without notice and we will not be responsible for any loss, cost, damage or liability that may arise as a result.
To the maximum extent permitted by law, in no event shall we be liable for any direct and indirect loss, damage or expense – irrespective of the manner in which it occurs – which may be suffered due to your use of our Platforms and/or the information or materials contained on it, or as a result of the inaccessibility of these Platforms and/or the fact that certain information or materials contained on it are incorrect, incomplete or not up-to-date.
This website utilises cookies. If you do not have cookies enabled in your web browser some functions of the site may not work as intended.